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Imidacloprid, a neonicotinoid insecticide, has been used worldwide due to its selective toxicity for insects. Its residues 
may enter the food chain, which is why it is important to investigate the potential adverse effects of imidacloprid exposure. 
This review summarises current knowledge of the reproductive toxicity and disruptive endocrine effects of imidacloprid 
in laboratory animals. Investigations, conducted mostly on laboratory rats, have shown adverse effects of imidacloprid 
on the reproductive ability in both parental and offspring generation as well as on the development of the offspring. Like 
many pesticides, imidacloprid may also act as endocrine disrupting chemical (EDC). It may disrupt the metabolic 
homeostasis, contribute to obesity, and disrupt steroidogenesis by inhibiting cytochrome P450 (CYP) enzyme activities. 
All these adverse effects of imidacloprid may pose a serious risk for reproduction and development with long-term 
consequences in adulthood.
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Neonicotinoid insecticides, the most important class of 
synthetic neuroactive insecticides, are widely used to treat 
crops and livestock against a broad range of pests (1, 2). 
Imidacloprid (IMI) [1-(6-chloro-3-pyridylmethyl)-N-nitro-
imidazolidin-2-ylideneamine] is a chlorinated analogue of 
nicotine and the first neonicotinoid registered for use as 
pesticide by the United States Environmental Protection 
Agency (US EPA). Since its introduction to the insecticide 
market in 1992, imidacloprid's use has been growing every 
year due to its selective toxicity and apparent safety for 
humans. Today, it accounts for 41.5 % of neonicotinoid use 
(2, 3). Imidacloprid is classified as a “Group E” carcinogen, 
which means that there is no evidence of carcinogenicity 
in humans (4). Neonicotinoid insecticides act as agonists 
of insect nicotinic acetylcholine receptors (nAChRs), which 
play an important role in synaptic transmission in the central 
nervous system (5). Due to structural differences between 
mammal and insect nAChRs and the higher binding affinity 
for insect nAChR, imidacloprid is considered a selective 
toxicant (6-8). Its oral LD50 in rats and mice is 450 and 
131 mg kg-1 of body weight (bw), respectively (9). Even 
though imidacloprid is mildly toxic to mammals, it may 
still affect their heart, kidney, and other organs and cause 
gastrointestinal irritation and neurological symptoms or 
even death. There are many reports indicating adverse 
effects of imidacloprid in mammals, such as teratogenic 
(10, 11), mutagenic (12), neurotoxic (13-15), and 
immunotoxic effects (16, 17). The toxicity of imidacloprid 
is dose-dependent, as reported by a study that evaluated 
effects of 30 days oral administration of 1/85 LD50 and 1/120 
LD50 of imidacloprid on thyroid toxicity in female rats (18) 
and a study of haematological and biochemical parameters 
in male rats after oral administration of 0.125 LD50 and 0.1 
LD50 of imidacloprid, which correspond to the levels found 
in and on treated cucumbers one hour and one day after the 
application of imidacloprid, respectively (19).
In this mini-review, however, we focus on the current 
knowledge of adverse effects of imidacloprid on the 
reproductive and endocrine function as evidenced by recent 
animal studies.
REPRODUCTIVE TOXICITY
Studies conducted in male and female laboratory 
animals, mostly rats, have established that oral administration 
of imidacloprid could affect reproductive function, as 
summarised in Table 1 (20-28). Subchronic and chronic 
exposure to different doses of imidacloprid can cause 
histological damage of the testicular tissue, changes in 
sperm morphology, increased sperm mortality and 
abnormality, decreased sperm count and motility, inhibited 
spermatogenesis, and reduced testosterone levels in male 
rats, all of which could lead to infertility (20-24).
More specifically, studies in male rats by Bal et al. (20, 
21) showed that a three-month exposure to imidacloprid 
doses lower than the no-observable-effect-level (NOEL), 
which is 5-10 mg kg-1 for rats, adversely affected their 
testicular function during early postnatal development and 
in adulthood. The elevated fatty acids and lipid peroxidation 
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and route of 
administration)
Dose(s) Effects






0.5, 2 and 
8 mg kg-1
↓ weights of epididymis, right cauda 
epididymis and seminal vesicle 
↓ epididymal sperm concentration at IMI – 
8 mg kg-1 
↑ abnormal sperm rates (head, tale and total 
values) at IMI – 8 mg kg-1 
↑ apoptosis and seminal DNA fragmentation 
at IMI – 2 and 8 mg kg-1 
↓ serum T 
↑ serum total cholesterol at IMI – 2 and 
8 mg kg-1 
↑ testicular fatty acids 
↑ MDA;  
↓ GSH in testis at IMI – 8  mg kg-1




0.5, 2 and 
8 mg kg-1
↓ weight of epididymis, right cauda 
epididymis and seminal vesicle 
↓ epididymal sperm concentration at IMI –  
2 and 8 mg kg-1 
↓ sperm motility at IMI – 8 mg kg-1 
↑ abnormal sperm rates (head, tale and total 
values) at IMI – 8 mg kg-1 
↑ apoptosis and seminal DNA fragmentation 
at IMI – 8 mg kg-1 
↓ serum T at IMI – 8 mg kg-1 
↓ GSH in testis at IMI – 8 mg kg-1 
↑ testicular fatty acids change in disturbance 
of fatty acid composition
Najafi et al. 





adverse histological changes on testicular 
tissue  
sperm mortality 
↑ abnormal sperm velocity 
↓ sperm viability 
↓ motile sperm velocity 
↓ T serum levels
Hafez et al. 
(23) 2016 male adult
15 days 
oral (gavage)
45, 90 and 
450 mg kg-1 
↓ LH, FSH, T, E2 and prolactin in testis 
↓ sperm count at 90 mg kg-1 
↓ motility and vitality 
affected sperm morphology at 45 and 
90 mg kg-1 
↓ spermatogenesis
Lonare et al. 





↓ total epididymal sperm count 
↓ sperm motility 
↓ live sperm count 
↑ sperm abnormalities (head and tail) 
↑ γ-GT, LDH-x, SDH in testis 
↓ T in plasma and testis 
↓ 3ẞ-HSD, 17ẞ-HSD in testis 
↑ LPO; ↓ GSH in testis 
↓ CAT, SOD at 90 mg kg-1 in testis 
↓ GPx and GST in testis 
histopathological alterations in testis and 
epididymis
105
(LPO) accompanied by lower glutathione (GSH) levels in 
the testes of the exposed rats resulted in impaired fertility, 
as evidenced by increased germ cell apoptosis and 
fragmentation of seminal DNA, lower serum testosterone 
level and higher rate of sperm abnormalities. The authors 
associated these adverse effects with the induction of 
oxidative stress in the testes, which are particularly sensitive 
to oxidative damage due to the presence of polyunsaturated 
fatty acids.
In female rats, Kapoor et al. (25) reported that exposure 
to imidacloprid (20 mg kg-1 day-1) for 90 days caused 
changes in the ovarian morphology, reduced its weight, and 
adversely affected serum follicle stimulating hormone 
(FSH), luteinizing hormone (LH), and progesterone levels. 
The authors also reported induced oxidative stress, 
evidenced by lower activity of superoxide dismutase (SOD), 
catalase (CAT), glutathione peroxidase (GPx), and GSH 
and increased LPO level.
These studies were the first to suggest the mechanisms 
of adverse imidacloprid effects on male and female 
reproduction. Later research reported higher LPO and lower 
GSH levels, as well as lower CAT, SOD, GPx, and 
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and route of 
administration)
Dose(s) Effects
Kapoor et al. 
(25) 2011 female adult
90 days 
oral
5, 10 and 
20 mg kg-1 
day-1
↓ ovarian weight at 20 mg kg-1 
significant pathomorphological changes in 
follicles, antral follicles and atretic follicles at 
20 mg kg-1 
↑ FSH; ↓ LH and P4 in serum at 20 mg kg-1 
↑ LPO in ovary at 20 mg kg-1 
↓ GSH, SOD, CAT and GPX in ovary at 
20 mg kg-1




from gestation day 
7 to 21, via tail 
vein
10 mg kg-1 
bw
↓ E2 and P in serum of 55-day-old offspring of 
IMI-treated mothers 
↓ ovarian weight, ovary diameter, number and 
diameter of follicles and corpus luteum in the 
offspring of IMI-treated mothers 
↓ rate of successful mating and number of fetus 
in the offspring of IMI-treated mothers 
down regulation of DAX1 gene in ovary of the 
offspring of IMI-treated mothers
Suter et al. (27) 
1990 female adult
P1/P2: 84 days/105 








↔ no reproductive effects 
↓ body weight gain in P1 at 700 ppm 
↓ food consumption in P1 at 700 ppm 
↓ body weight gain in P1 – offspring until 
weaning at 700 ppm 
↓ premating body weights in P1-F1 males at 
700 ppm




F0 females: 10 
weeks or more 
F1 parents: 8 
weeks or more 
oral
10 and 20 
mg kg -1 
bw day-1
↓ ovarian weight in F0 and F1 generation at 
20 mg kg-1 bw day-1 
↑ body weight of F0 pups (day 0) 
↓ body weight of F1 pups (day 21) 
histopathology of ovary revealed different 
stages of follicles 
↑ ALT in F1 and F2 females 
↑ body weight of F1 pups on day 0 at 
20 mg kg-1 bw day-1 
↓ body weight in F2 pups on day 21 at 
20 mg kg-1 bw day-1 
↓ food consumption in IMI treated females of 
F0 and F1 generation
Abbreviations: ↑=increase; ↓= decrease; ↔ = no effect; ALT=alanine aminotransferase; bw=body weight; CAT=catalase; 
E2=oestradiol; F1/2=first/second generation of offspring; FSH=follicular stimulating hormone; GPx=glutathione peroxidase; γ- 
GSH=reduced glutathione; GST= glutathione-S-transferase; GT= gamma-glutamyl transpeptidase; 3ẞ-HSD= 3ẞ-hydroxysteroid 
dehydrogenase; 17ẞ-HSD= 17ẞ-hydroxysteroid dehydrogenase; IMI = imidacloprid; LDH-x= lactate dehydrogenase-x; LH=luteinizing 
hormone; LPO=lipid peroxidation; P4=progesterone; P/F0=parental generation; SDH=sorbitol dehydrogenase; SOD=superoxide 
dismutase; T=testosterone
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glutathione S-transferase (GST) activities in male rats 
exposed to higher doses of imidacloprid (45 and 90 mg kg-1 
bw, corresponding to 1/10 and 1/5 of LD50) for 28 days and 
confirmed that oxidative stress is the mechanism that leads 
to reproductive toxicity of imidacloprid (24).
Reproductive toxicity of imidacloprid was also studied 
following in utero exposure of the female offspring of 
pregnant rats receiving 10 mg kg-1 bw of imidacloprid 
through the tail vein from gestation day 7 to 21 (26). The 
offspring showed disrupted follicular development, lower 
oestradiol and progesterone levels, lower ovarian weight 
and diameter as well as decrease in the rate of successful 
mating and reduction in foetal number due to down-
regulation of ovarian DAX1 gene compared to controls.
In a two-generation, two-litter study in rats Suter et al. 
(27) reported no adverse effects on the reproductive function 
or birth defects of imidacloprid exposure before and during 
mating, gestation, and lactation. However, the authors found 
decreased body weight in mother rats and male and female 
offspring that was associated with reduced food consumption 
at dietary imidacloprid dose of 700 ppm (corresponding to 
47 mg kg-1 bw day-1). In a three-generation reproductive 
study (28) oral administration of 20 mg kg-1 bw day-1 of 
imidacloprid affected body weight and food consumption 
and caused only minimal effects on the reproductive 
performance such as reduction in fertility index in the 
second and third generation.
Neurotoxicity as the consequence of imidacloprid 
exposure in utero has been investigated in rat offspring by 
Abou-Donia et al. (29). Gestational exposure to a single 
large dose (0.75 of the LD50) of imidacloprid caused 
developmental neurobehavioral deficits and increased the 
expression of glial fibrillary acidic protein (GFAP) in the 
brain regions of 30-day-old offspring with possible long-
term adverse health effects. An in vitro investigation by Gu 
et al. (30) has shown adverse effects of direct exposure to 
imidacloprid on the sperm function and embryonic 
development that may also present a risk for human 
reproductive health.
Investigations in other laboratory animals showed no 
adverse effects of imidacloprid exposure on the early 
development of the zebrafish (Danio rerio) (31), but in male 
rabbits (Oryctolagus cuniculus) it was associated with 
testicular damage that can lead to infertility and reproductive 
disorders (32).
ENDOCRINE DISRUPTION
Many pesticides, including imidacloprid, can affect the 
normal functioning of animal endocrine systems by 
interfering with natural hormones. Due to their strong 
affinity for oestrogen and androgen receptors, they can 
activate these receptors and mimic hormonal action or block 
the receptors and inhibit their action. In addition, endocrine 
disrupting pesticides can interfere with the synthesis, 
secretion, transport, metabolism, binding, or elimination of 
natural hormones (32).
Some investigations imply that exposure to 
environmental endocrine disruptors could be the generative 
cause of obesity (34, 35). This may also be true for 
endocrine disrupting pesticides. Imidacloprid's role in 
obesity was investigated in a study in which mice were 
exposed to low doses (0.5 % of the LD50) of dithiocarbamate 
mancozeb and imidacloprid from postnatal day 1 to weaning 
(postnatal day 28) through lactating mother. The exposure 
to individual pesticides did not disrupt hormonal/metabolic 
homeostasis or affect body weight gain, but exposure to 
their combination did (36). An in silico study by the same 
authors showed that imidacloprid and mancozeb disrupted 
steroid hormone biosynthesis by impairing the activities of 
the cytochrome P450 (CYP) enzymes that have a key role 
in the synthesis and breakdown of various steroid hormones 
(37). Several studies have shown that imidacloprid 
potentiates adipogenesis in 3T3-L1 adipocytes and induces 
insulin resistance in C2C12 myotubes (38, 39). The same 
group of authors reported that oral exposure to low doses 
(0.6 and 6 mg kg-1 bw day-1) of imidacloprid for 12 weeks 
in male and female C57BL/6J mice enhanced high fat-diet 
adiposity by mechanisms that still need to be clarified. 
Insulin resistance observed in male mice was not confirmed 
in females, which was explained by potential sex differences 
(40, 41).
CONCLUSION
Animal study evidence is pretty clear about the risks 
involved in imidacloprid exposure for male and female 
reproduction. It may alter essential reproductive functions 
by affecting hormone levels and cause reproductive organ 
disruption and suppression of their function, which may 
lead to infertility. In utero exposure to imidacloprid can 
significantly affect offspring development with lasting 
adverse consequences in adulthood. The European 
Commission has restricted the use of imidacloprid and two 
other neonicotinoids since 2013 due to their potential role 
in the collapse of the bee population (42). The updated risk 
assessment report regarding neonicotinoids was issued by 
the European Food Safety Authority in February 2018 (43). 
Although it points to risks for honeybees, the decision 
regarding a possible EU-wide ban of neonicotinoids was 
not made and remains the responsibility of the European 
Commission and Member state authorities. Nevertheless, 
since imidacloprid is still widely used, more measures 
should be taken to minimise its adverse effects.
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Imidakloprid kao reprodukcijski toksikant i endokrini disruptor: istraživanja na laboratorijskim životinjama
Imidakloprid, neonikotinoidni insekticid, koristi se diljem svijeta zbog svoje selektivne toksičnosti za insekte. S obzirom 
na to da njegovi ostaci mogu ući u hranidbeni lanac, važno je istražiti potencijalno štetne učinke izloženosti imidaklopridu. 
U ovom preglednom radu prikazani su podaci o reprodukcijskoj toksičnosti imidakloprida i njegovim učincima kao 
hormonskog otrova u laboratorijskih životinja. Istraživanja koja su provedena uglavnom na laboratorijskim štakorima 
pokazala su štetne učinke imidakloprida na reprodukciju roditelja i potomstva, kao i na razvoj potomstva. Poput mnogih 
pesticida, imidakloprid može djelovati i kao hormonski otrov te poremetiti ne samo metaboličku ravnotežu i pridonijeti 
povećanju pretilosti nego i steroidogenezu inhibicijom aktivnosti sustava enzima citokrom P-450 (CYP). Svi ti štetni 
učinci imidakloprida mogu predstavljati ozbiljan rizik za reprodukciju i razvoj s dugoročnim štetnim posljedicama u 
odrasloj dobi.
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